Heparin administration leads to rapid decrease in plasma matrix metalloproteinase-9

International Journal of Cardiology

Volumn 163, Issue 2, 2013, Pages 212-213

  Lee, Regent ^a   Adlam, David ^a   Antoniades, Charalambos ^a   Digby, Janet E ^a   Kharbanda, Rajesh K ^a   Choudhury, Robin P ^a   Channon, Keith M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Biomarker; Coronary artery disease; Heparin; Matrix metalloproteinase 9; MMP9; Preanalytic issue

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; HEPARIN; EDETIC ACID;

CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; HUMAN; LETTER; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; AGED; ANGIOCARDIOGRAPHY; BLOOD ANALYSIS EQUIPMENT; BLOOD SAMPLING; DRUG EFFECT; ENZYME ANALYSIS; ENZYME REPRESSION; FEMALE; IMMUNOLOGY TEST KIT; MALE; QUANTITATIVE ANALYSIS;

EID: 84873409720     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.06.105     Document Type: Article

References (6)

1. A.C. Newby Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture Physiol Rev 85 2005 1 31
2. K. Jung, C. Laube, and M. Lein Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood Clin Chem 44 1998 1060 1062
3. A. Meisser, M. Cohen, and P. Bischof Concentrations of circulating gelatinases (matrix metalloproteinase-2 and -9) are dependent on the conditions of blood collection Clin Chem 51 2005 274 276
4. H. Piccard, P.E. Van den Steen, and G. Opdenakker Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins J Leukoc Biol 81 2007 870 892
5. G.W. Stone, B. Witzenbichler, and G. Guagliumi Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Lancet 377 2011 2193 2204
6. A.J. Coats, and L.G. Shewan Statement on authorship and publishing ethics in the International Journal of Cardiology Int J Cardiol 153 2011 239 240